Journal article
Host cell reactivation of cisplatin-treated adenovirus is reduced in nucleotide excision repair deficient mammalian cells and several human tumour cells.
Abstract
Cisplatin is widely used for chemotherapy of a variety of human cancers. Cisplatin exerts its toxic effect by covalently binding to DNA, resulting in monofunctional adducts, intrastrand crosslinks, and interstrand crosslinks. Several recent reports suggest that the cellular capacity for DNA repair, especially nucleotide excision repair (NER), is an important determinant in the sensitivity of cells to cisplatin. We have used a sensitive host …
Authors
Bulmer J; Davis K; Rainbow A
Journal
International Journal of Oncology, Vol. 9, No. 6, pp. 1121–1127
Publisher
Spandidos Publications
Publication Date
December 1996
DOI
10.3892/ijo.9.6.1121
ISSN
1019-6439